Drug Level-based Anti-Tumor Necrosis Factor Therapy: Ready for Prime Time?
Department of Gastroenterology, Sheba Medical Center Tel Hashomer, Sackler School of Medicine, Tel-Aviv University, Tel Hashomer, Israel. Electronic address: shomron.benhorin@gmail.com.
Shomron
S
Ben-Horin
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage* / Q000097:blood*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000097:blood*; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D003424:Crohn Disease / Q000188:drug therapy*; D016903:Drug Monitoring; D005260:Female; D005765:Gastrointestinal Agents / Q000008:administration & dosage* / Q000097:blood*; D006801:Humans; D008297:Male
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents